Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Nektar Therapeutics
NKTR
$2.53B
| $44.2M | 0.09% |
269,001
+242,661
| +921% | +$42.9M |
|
277
Associated Banc-Corp
ASB
$5.82B
| $44.1M | 0.09% |
2,456,399
+1,742,134
| +244% | +$33.2M |
|
278
Canadian Solar
CSIQ
$988M
| $44.1M | 0.09% |
2,653,680
+535,519
| +25% | +$11.9M |
|
279
Sun Communities
SUI
$14.8B
| $43.4M | 0.08% |
640,480
+280,360
| +78% | +$18.7M |
|
|
HDS
280
DELISTED
HD Supply Holdings, Inc.
HDS
| $43.3M | 0.08% |
1,511,926
+528,325
| +54% | +$17.7M |
|
281
Ashland
ASH
$3.33B
| $43.2M | 0.08% |
878,483
+88,019
| +11% | +$4.79M |
|
282
Brookdale Senior Living
BKD
$2.82B
| $43.1M | 0.08% |
1,877,001
+96,637
| +5% | +$2.85M |
|
283
Cardinal Health
CAH
$53.4B
| $42.2M | 0.08% |
549,695
+6,769
| +1% | +$566K |
|
|
BDN
284
Brandywine Realty Trust
BDN
$522M
| $42.2M | 0.08% |
3,425,507
+1,189,716
| +53% | +$15.5M |
|
285
Eli Lilly
LLY
$1.12T
| $42M | 0.08% |
+501,617
| New | +$42.3M |
|
|
ESV
286
DELISTED
Ensco Rowan plc
ESV
| $41.9M | 0.08% |
743,373
-50,793
| -6% | -$3.5M |
|
287
Alibaba
BABA
$286B
| $41.8M | 0.08% |
709,003
+221,526
| +45% | +$16.1M |
|
288
Hain Celestial
HAIN
$71.6M
| $41.8M | 0.08% |
+809,921
| New | +$51.3M |
|
289
Arthur J. Gallagher & Co
AJG
$67.6B
| $41.8M | 0.08% |
1,011,380
-31,830
| -3% | -$1.44M |
|
|
HPP
290
Hudson Pacific Properties
HPP
$787M
| $41.6M | 0.08% |
206,179
-61,253
| -23% | -$12.7M |
|
|
JNPR
291
DELISTED
Juniper Networks
JNPR
| $41.5M | 0.08% |
1,612,580
-478,290
| -23% | -$12.6M |
|
292
Sabre
SABR
$848M
| $41.4M | 0.08% |
1,521,653
+1,056,373
| +227% | +$28.6M |
|
293
Agnico Eagle Mines
AEM
$109B
| $41.3M | 0.08% |
1,629,793
+970,983
| +147% | +$23.6M |
|
294
Halozyme
HALO
$12.3B
| $41.2M | 0.08% |
3,067,386
-2,433,305
| -44% | -$48.9M |
|
295
Franklin Templeton
BEN
$17.4B
| $41.1M | 0.08% |
1,102,315
+861,837
| +358% | +$37.3M |
|
296
Darden Restaurants
DRI
$25.2B
| $41M | 0.08% |
+669,614
| New | +$42.5M |
|
297
Incyte
INCY
$25.9B
| $41M | 0.08% |
371,453
-4,175
| -1% | -$468K |
|
|
OA
298
DELISTED
Orbital ATK, Inc.
OA
| $40.5M | 0.08% |
563,384
+86,398
| +18% | +$6.41M |
|
299
Take-Two Interactive
TTWO
$44.8B
| $40.4M | 0.08% |
1,407,127
-867,895
| -38% | -$25.8M |
|
300
Strategy Inc
MSTR
$47.4B
| $40.4M | 0.08% |
2,056,040
+686,800
| +50% | +$13.6M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.